Hongjiu Fruit: Jiang Zongying, the controlling shareholder and executive director, pledged 21 million H shares of the company. Hongjiu Fruit (06689) announced that the company had learned that Ms. Jiang Zongying, the controlling shareholder and executive director of the company, had pledged the company's shares on December 11, 2024. Because the company failed to return the relevant funds to the subscriber within the time limit stipulated in the termination agreement, Ms. Jiang pledged 21 million H shares of the company to the subscriber as the company's subsequent refund of the relevant funds to the subscriber.CEO of STELLANTIS Europe: We will never pay a fine for the EU emission reduction requirements in 2025, and we are ready to reduce production to avoid this situation.Institution: The Swiss National Bank does not need to cut interest rates sharply again. Melanie Debono, a macroeconomic analyst at Pantheon, wrote in a report that the Swiss National Bank does not need to cut borrowing costs sharply again. Earlier, the Swiss National Bank unexpectedly cut interest rates by 50 basis points. Most analysts had expected a more cautious rate cut of 25 basis points. Debono said that there may be further relaxation after this move, but only a little. Pantheon Macroeconomics predicts that the Swiss National Bank will cut interest rates by 25 basis points again in March next year.
The number of employed people in Australia increased by 35,613 in November, and it is estimated to be 25,000.CITIC Securities: The resonance between supply and demand of medical beauty accelerates the space expansion, and the difference in operating ability promotes the evolution of the industry structure. CITIC Securities Research Report stated that the medical beauty industry has both medical and consumption attributes, and the medical attribute has strong product-driven characteristics, while the consumption attribute has high operating ability requirements. The medical beauty botulinum toxin track is also affected by the dual attributes of medicine and consumption: 1) The increase in penetration rate, the acceleration of compliance substitution and the extension of indications have brought about high demand for medical beauty botulinum toxin, and with the recent supply expansion, the industry scale has experienced high growth; 2) The iteration of product innovation is slow, brand barriers are created through marketing, doctors are empowered through direct sales, and control is strengthened to enhance product competitiveness. Recently, a variety of medical botulinum toxins in China have been approved, and the promotion of low-priced products is expected to push up the penetration rate, and enterprises with strong operational capabilities will enter the market or promote the evolution of the pattern.OPENAI said that it is working hard to solve the current fault problem.
Ministry of Health of Gaza: Since October 7, 2023, 44,835 Palestinians have been killed and 106,356 injured in Israeli military attacks on the Gaza.Yuncong Technology: "The R&D team of large-scale model agent products is basically dissolved" is all false information. Yuncong Technology said on the interactive platform that the company's R&D team is stable at present, and a rigorous and meticulous hierarchical division of labor system has been established for the research and development of large-scale model related products. The configuration of R&D echelon will be flexibly adjusted according to the continuous evolution of large model technology and the changes of market demand of agent products. The statements of "the No.1 position of the big model algorithm" and "the R&D team of the big model agent product is basically dissolved" mentioned in the question are false information, and the company reserves the right to pursue legal responsibility for this. The company has been unswervingly promoting the research and product development of large-scale model and agent-related technologies.Zhonggong Education: Director Yi Ziting resigned due to retirement. Zhonggong Education announced that the company's board of directors recently received a written resignation report from Director Yi Ziting. Yi Ziting applied to the company's board of directors for resignation due to retirement, and will not hold other positions in the company after resignation.
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14